Treatment of depressive and anxiety disorders during pregnancy and lactation: A case study DOI Creative Commons

Teodora Inić,

Mina Cvjetković-Bošnjak, Dušan Kuljančić

et al.

SANAMED, Journal Year: 2024, Volume and Issue: 19(3), P. 319 - 324

Published: Jan. 1, 2024

Introduction: Depressive and anxiety disorders are among the most common psychiatric conditions, as stated by WHO in 2015. These often manifest during adolescence or young adulthood, making it unsurprising for women pregnancy lactation periods to experience either a first manifestation recurrence of symptoms. When these occur lactation, antidepressant treatment may be required per established protocols. However, concerns arise patients, such as: "Is this medication safe me my baby? Could negatively affect baby's development?" hesitations can sometimes extend healthcare providers if they lack adequate education on topic. Therapeutic guidelines worldwide recommend psychotherapy mild symptoms, whereas pharmacotherapy, combined with , is carefully considered moderate Case Report: This paper presents three case studies pregnant depressive disorders. The involves patient prenatal depression who achieved complete remission after starting therapy. second highlights symptoms following dis-continuation psychopharmaceuticals. third emphasizes importance individualized plans illustrates previously remission. Conclusion: Pregnant mental health challenges have significant about using psychopharmaceuticals pregnancy. aims underscore that appropriate selection dosage medications lead without adverse effects mother child.

Language: Английский

Antidepressant aripiprazole induces adverse effects on neural development during cortex organoid generation DOI

Youngin Jeong,

S.-P. Son,

Ji‐Yun Park

et al.

Reproductive Toxicology, Journal Year: 2025, Volume and Issue: unknown, P. 108862 - 108862

Published: Feb. 1, 2025

Language: Английский

Citations

0
Effect of prenatal online interventions on postpartum depressive symptoms and well-being: a systematic review and meta-analysis DOI
A Savoia, Simona Scaini, Francesca Wanda Rossi

et al.

Archives of Women s Mental Health, Journal Year: 2025, Volume and Issue: unknown

Published: March 15, 2025

Language: Английский

Citations

0
Obstetric Outcomes in Women on Lithium: A Systematic Review and Meta-Analysis DOI Open Access
Tommaso Callovini, Silvia Montanari, Francesca Bardi

et al.

Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(16), P. 4872 - 4872

Published: Aug. 18, 2024

Background/Objectives: Lithium taken during pregnancy was linked in the past with increased risk for foetal/newborn malformations, but clinicians believe that it is worse newborn children not to treat mothers’ underlying psychiatric illness. We set review available evidence of adverse foetal outcomes women who received lithium treatment some time their pregnancy. Methods: searched four databases and a register seek papers reporting neonatal took by using appropriate terms. adopted PRISMA statement used Delphi rounds among all authors assess eligibility Cochrane Risk-of-Bias tool evaluate RoB included studies. Results: found 28 eligible studies, 10 which met criteria inclusion meta-analysis. The studies regarded 1402 babies 2595 exposed lithium. Overall, systematic slightly taking both first trimester only any pregnancy, while meta-analysis odds cardiac or other preterm birth, large size gestational age at Conclusions: Women BD planning should consider discontinuing when euthymic; use increases outcomes. Once has started, there no reason lithium; close monitoring regular blood levels may obviate disadvantages administration

Language: Английский

Citations

3
Exploring genetic causal relationship between antidepressants use and congenital malformations DOI

Kaiyan Yang,

Xinyu Qin,

Huiyang Wang

et al.

Reproductive Toxicology, Journal Year: 2024, Volume and Issue: unknown, P. 108736 - 108736

Published: Oct. 1, 2024

Language: Английский

Citations

1
Side effects of antidepressant use in pregnancy DOI

Stephanie L. Zeszutek,

Sukhmani Kaur,

Sashah Seher Shariff

et al.

Side effects of drugs annual, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 5

Published: Jan. 1, 2024

Language: Английский

Citations

0
Treatment of depressive and anxiety disorders during pregnancy and lactation: A case study DOI Creative Commons

Teodora Inić,

Mina Cvjetković-Bošnjak, Dušan Kuljančić

et al.

SANAMED, Journal Year: 2024, Volume and Issue: 19(3), P. 319 - 324

Published: Jan. 1, 2024

Introduction: Depressive and anxiety disorders are among the most common psychiatric conditions, as stated by WHO in 2015. These often manifest during adolescence or young adulthood, making it unsurprising for women pregnancy lactation periods to experience either a first manifestation recurrence of symptoms. When these occur lactation, antidepressant treatment may be required per established protocols. However, concerns arise patients, such as: "Is this medication safe me my baby? Could negatively affect baby's development?" hesitations can sometimes extend healthcare providers if they lack adequate education on topic. Therapeutic guidelines worldwide recommend psychotherapy mild symptoms, whereas pharmacotherapy, combined with , is carefully considered moderate Case Report: This paper presents three case studies pregnant depressive disorders. The involves patient prenatal depression who achieved complete remission after starting therapy. second highlights symptoms following dis-continuation psychopharmaceuticals. third emphasizes importance individualized plans illustrates previously remission. Conclusion: Pregnant mental health challenges have significant about using psychopharmaceuticals pregnancy. aims underscore that appropriate selection dosage medications lead without adverse effects mother child.

Language: Английский

Citations

0